Catalyst Wire Dossier Catalyst Wire Dossier

SI-613

· Seikagaku Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SI-613, covering 2021-09-16 to 2021-09-16. Get the full timeline:

Most recent: Clinical Trial Update: SI-613 Study for Knee Osteoarthritis [Phase 2]

See pricing